Greenrose Acquisition Corp. (GNRS): Price and Financial Metrics
GET POWR RATINGS... FREE!
GNRS Stock Price Chart Interactive Chart >
GNRS Price/Volume Stats
| Current price | $1.77 | 52-week high | $10.62 |
| Prev. close | $2.04 | 52-week low | $1.05 |
| Day low | $1.77 | Volume | 1,700 |
| Day high | $2.02 | Avg. volume | 5,443 |
| 50-day MA | $3.12 | Dividend yield | N/A |
| 200-day MA | $6.24 | Market Cap | 30.55M |
Greenrose Acquisition Corp. (GNRS) Company Bio
Greenrose Acquisition Corp. does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the cannabis industry. The company was founded in 2019 and is based in Woodbury, New York.
Latest GNRS News From Around the Web
Below are the latest news stories about Greenrose Holding Co Inc that investors may wish to consider to help them evaluate GNRS as an investment opportunity.
The Greenrose Holding Company Closes Asset Purchase of True Harvest, LLC- True Harvest Expands Greenrose’s Footprint into Arizona and Establishes Strong Cultivation Presence in the Southwest - - Greenrose Provides Revised 2022 Outlook for True Harvest and Theraplant - AMITYVILLE, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) (“Greenrose” or the “Company”) announced that it closed its previously announced acquisition of the assets of Arizona-based True Harvest, LLC. Under the terms of the acquisition, Greenrose paid con |
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Greenrose Acquisition Corp. - GNRSNEW YORK, NY / ACCESSWIRE / December 14, 2021 / Pomerantz LLP is investigating claims on behalf of investors of Greenrose Acquisition Corp. ("Greenrose" or the "Company") (OTCQX:GNRS). |
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Greenrose Acquisition Corp. (GNRS) InvestigationNEW YORK, NY / ACCESSWIRE / December 1, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Greenrose Acquisition Corp. ("Greenrose" or the "Company") (OTCMKTS:GNRS). |
Greenrose Acquisition Corp. Announces Closing of Business Combination with TheraplantGreenrose to Continue Trading on the OTC Under Ticker Symbol GNRS Greenrose to Continue Trading on the OTC Under Ticker Symbol GNRS |
Greenrose Acquisition Corp. Stockholders Approve Business Combination- All Stockholder Proposals Were Approved - - Transaction Expected to Close Early November - AMITYVILLE, N.Y., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) (“Greenrose” or the “Company”), a special purpose acquisition company targeting companies in the cannabis industry, announced today that its shareholders voted to approve the proposed business combination (the “Business Combination”) with Connecticut-based Theraplant, LLC and the acquisition of certa |
GNRS Price Returns
| 1-mo | -45.54% |
| 3-mo | -66.29% |
| 6-mo | -79.89% |
| 1-year | -82.26% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -45.54% |
| 2021 | -67.92% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...